Paolo Cremaschi

4PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 01, 2026
The RNA cargo of plasma-derived extracellular vesicles in mCRPC patients captures cancer cells and tumor microenvironment signals.

|Oct 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer.

Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas

|Aug 19, 2024
An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma.

Katia Grillone, Serena Ascrizzi, Paolo Cremaschi

|Aug 10, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.

A M Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog

Pageof 1

Frequent Collaborators

3 joint publications

Gerhardt Attard

2 joint publications

Daniel Wetterskog

2 joint publications

Francesca Demichelis

2 joint publications

Umberto Basso